Ultime notizie per Minerva Surgical (OTC:UTRS) Azioni

Minerva Surgical

Minerva Surgical Inc is a medical device company that develops therapeutic devices that treat abnormal uterine bleeding in a minimally invasive manner. The Company operates and manages its business as one reportable and operating segment, which is the business of research, development, and sale of therapeutic devices for abnormal uterine bleeding treatment.

MINERVA SURGICAL INC NEW by Minerva Surgical, Inc.

Minerva Surgical Inc

HC Wainwright &amp; Co. analyst Edward White maintains Aura Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AURA#NASDAQ">AURA</a>) with a Buy and raises the price target from $21 to $22.

News

Price Target

Analyst Ratings

AURA

HC Wainwright & Co. Maintains Buy on Aura Biosciences, Raises Price Target to $22

The collaboration supports the licensing of part of Curiosity Stream&#39;s content portfolio in China, Hong Kong, and Macau, bringing 56 unique titles, amounting to 148 hours of premium factual content, to audiences across these territories through various platforms. The deal encompasses a diverse range of programming, from short-form documentary series to premium long-form content.

CURI

Curiosity Inks Strategic Distribution Partnership With Off The Fence; Deal Broadens Company's Footprint Across China, Hong Kong, And Macau

Guidance

CVS's Q3 Results Won't Meet Wall Street's Expectations; Plans To Back Away From Current 2024 Guidance

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates DRDGold (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRD#NYSE">DRD</a>) with a Buy and maintains $13.25 price target.

Reiteration

HC Wainwright & Co. Reiterates Buy on DRDGold, Maintains $13.25 Price Target

Management

CVS Naming Caremark President David Joyner As Its New CEO

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates Avino Silver &amp; Gold Mines (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ASM#AMEX">ASM</a>) with a Buy and maintains $1.5 price target.

HC Wainwright & Co. Reiterates Buy on Avino Silver & Gold Mines, Maintains $1.5 Price Target

Biotech

Large Cap

Health Care

General

The European Medicines Agency's Committee For Medicinal Products For Human Use Has Adopted A Positive Opinion, Recommending Approval Of Novo Nordisk's Alhemo (Concizumab) As The First Once-Daily Subcutaneous Prophylactic Treatment For People Aged 12 Years Or Older With Hemophilia A Or B With Inhibitors.

HC Wainwright &amp; Co. analyst Heiko Ihle reiterates First Majestic Silver (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AG#NYSE">AG</a>) with a Buy and maintains $8.5 price target.

HC Wainwright & Co. Reiterates Buy on First Majestic Silver, Maintains $8.5 Price Target

The combined companies for the trailing twelve months have generated $235 million in revenue, increasing approximately&nbsp;25%&nbsp;quarter-over-quarter.

BTTR

Better Choice Expects Combined 2025 Pro Forma Basis Revenue And EBITDA To Be Approximately +$270M, And +$10M, Respectively

Better Choice Says Continues To Make Progress Towards Closing Of Its Acquisition Of SRx Health Solutions; Expects Transaction To Close In Late Q4 Of This Year Or Early Q1 Of 2025

Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRA#NASDAQ">NMRA</a>) with a Buy and maintains $23 price target.

NMRA

Needham Reiterates Buy on Neumora Therapeutics, Maintains $23 Price Target

Based on sales trends and order intake in recent years, it expects further market share gains with domestic Chinese OEMs in the coming years.
With the seasonally strong fourth quarter remaining of the year, it reaffirms&nbsp;guidance of around 9.5-10.0% adjusted operating margin for 2024, but to be at the low end of this range.
&nbsp;

Autoliv Now Expects Full Year 2024 Organic Sales Growth To Be 1% Instead Of Previously Expected 2% Due To Unfavorable Market Mix Development

Regions Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RF#NYSE">RF</a>) reported quarterly earnings of $0.57 per share which beat the analyst consensus estimate of $0.53 by 7.55 percent. This is a 16.33 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $1.87 billion which beat the analyst consensus estimate of $1.80 billion by 3.78 percent. This is a 0.54 percent increase over sales of $1.86 billion the same period last year.

Earnings

Earnings Beats

Regions Finl Q3 Adj $0.57 Beats $0.53 Estimate, Sales $1.87B Beat $1.80B Estimate

HC Wainwright &amp; Co. analyst Patrick Trucchio reiterates Alnylam Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALNY#NASDAQ">ALNY</a>) with a Buy and maintains $400 price target.

ALNY

HC Wainwright & Co. Reiterates Buy on Alnylam Pharmaceuticals, Maintains $400 Price Target

Autoliv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ALV#NYSE">ALV</a>) reported quarterly earnings of $1.84 per share which missed the analyst consensus estimate of $1.95 by 5.64 percent. The company reported quarterly sales of $2.56 billion which beat the analyst consensus estimate of $2.53 billion by 0.89 percent. This is a 1.58 percent decrease over sales of $2.60 billion the same period last year.

Earnings Misses

Autoliv Q3 2024 Adj EPS $1.84 Misses $1.95 Estimate, Sales $2.56B Beat $2.53B Estimate

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.

GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

Needham analyst Ami Fadia reiterates Avadel Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVDL#NASDAQ">AVDL</a>) with a Buy and maintains $22 price target.

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

Needham Reiterates Buy on Avadel Pharmaceuticals, Maintains $22 Price Target

Needham analyst Mayank Tandon maintains WNS (Hldgs) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WNS#NYSE">WNS</a>) with a Buy and lowers the price target from $70 to $60.

Needham Maintains Buy on WNS (Hldgs), Lowers Price Target to $60

Needham analyst Kyle Peterson reiterates Equifax (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFX#NYSE">EFX</a>) with a Buy and maintains $350 price target.

Needham Reiterates Buy on Equifax, Maintains $350 Price Target

Needham analyst Mike Matson downgrades Boston Scientific (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BSX#NYSE">BSX</a>) from Buy to Hold and maintains the price target from $86 to $86.

Downgrades

Needham Downgrades Boston Scientific to Hold, Maintains Price Target to $86

VTGN, CERE and RVPH are among pre market gainers

The 47 rating InvestorsObserver gives to Minerva Surgical Inc (UTRS)  stock puts it near the top of the Health Information Services industry. In addition to scoring higher than 72 percent of stocks in the Health Information Services industry, UTRS's 47 overall rating means the stock scores better than 47 percent of all sto

Is Minerva Surgical Inc (UTRS) a Good Buy in the Health Information Services Industry?

Overall market sentiment has been high on Minerva Surgical Inc (UTRS)  stock lately. UTRS receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator. Minerva Surgical Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on UTRS!See Full UTRS ReportWhat is St

Is it Time to Dump Minerva Surgical Inc (UTRS) Stock After it Has Gained 15.35% in a Week?

Minerva Surgical Inc (UTRS) is down -53.55%% today. UTRS has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on UTRS!See Full UTRS ReportUTRS stock closed at $2.82 and is down -$1.51 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as

Minerva Surgical Inc (UTRS) Down 53.55% in Premarket Trading

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the week with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Monday!



Moving stocks are an acquisition deal, delisting update, bankruptcy filing and more.



Let&rsquo;s get into that news down below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Royalty Management (NASDAQ:<a href="https://investorplace.com/stock-quotes/rmco-stock-quote/">RMCO</a>) stock is rocketing close to 53% without any clear news this morning.</li>



<li>Alaunos Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/tcrt-stock-quote/">TCRT</a>) shares are soaring more than 51% alongside heavy pre-market trading.</li>



<li>iCoreConnect (NASDAQ:<a href="https://investorplace.com/stock-quotes/icct-stock-quote/">ICCT</a>) stock is surging over 34% with strong early morning trading. </li>



<li>United States Steel (NYSE:<a href="https://investorplace.com/cryptocurrency/x/">X</a>) shares are increasing more than 27% on <a href="https://www.wsj.com/business/deals/nippon-steel-to-acquire-u-s-steel-for-55-shr-854c6f73?siteid=yhoof2">an acquisition deal</a> with Nippon Steel (OTCMKTS:<a href="https://investorplace.com/stock-quotes/npscy-stock-quote/">NPSCY</a>).</li>



<li>Wheeler Real Estate IT (NASDAQ:<a href="https://investorplace.com/stock-quotes/whlr-stock-quote/">WHLR</a>) stock is rising over 27% on news of <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317929244&amp;type=PDF&amp;symbol=WHLR&amp;cdn=89e511f6d2f3449c44aea0eea02765a3&amp;companyName=Wheeler+Real+Estate+Investment+Trust+Inc.&amp;formType=SC+13D&amp;formDescription=General+statement+of+acquisition+of+beneficial+ownership&amp;dateFiled=2023-12-15">an investment in the company</a>.</li>



<li>Banzai International (NASDAQ:<a href="https://investorplace.com/stock-quotes/bnzi-stock-quote/">BNZI</a>) shares are gaining more than 27% without any obvious news.</li>



<li>Arcutis Biotherapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/arqt-stock-quote/">ARQT</a>) stock is heading over 23% higher following <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317931878&amp;type=PDF&amp;symbol=ARQT&amp;cdn=44d83c9baa25d3a828cecfbba6d4204c&amp;companyName=Arcutis+Biotherapeutics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-12-18">approval of a new drug application</a>.</li>



<li>Shineco (NASDAQ:<a href="https://investorplace.com/stock-quotes/sisi-stock-quote/">SISI</a>) shares are getting a more than 21% boost on Monday morning.</li>



<li>Ontrak (NASDAQ:<a href="https://investorplace.com/stock-quotes/otrk-stock-quote/">OTRK</a>) stock is jumping over 20% today.</li>



<li>Arrival (NASDAQ:<a href="https://investorplace.com/stock-quotes/arvl-stock-quote/">ARVL</a>) shares are up more than 18% on Monday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Ebix (NASDAQ:<a href="https://investorplace.com/stock-quotes/ebix-stock-quote/">EBIX</a>) stock is crashing over 53% alongside <a href="https://www.nasdaq.com/press-release/ebix-reaches-stalking-horse-sale-agreement-for-life-insurance-and-annuity-business">a bankruptcy filing</a>.</li>



<li>Minerva Surgical (NASDAQ:<a href="https://investorplace.com/stock-quotes/utrs-stock-quote/">UTRS</a>) shares are plummeting more than 51% as it <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317930347&amp;type=PDF&amp;symbol=UTRS&amp;cdn=c7474a358ea939d3c2d596e1cff4f9b4&amp;companyName=Minerva+Surgical+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-12-15">prepares to be delisted</a>. </li>



<li>Gaotu Techedu (NYSE:<a href="https://investorplace.com/stock-quotes/gotu-stock-quote/">GOTU</a>) stock is diving over 22% despite a lack of news this morning.</li>



<li>Chavant Capital (NASDAQ:<a href="https://investorplace.com/stock-quotes/clay-stock-quote/">CLAY</a>) shares are tumbling more than 20% this morning.</li>



<li>Ainos (NASDAQ:<a href="https://investorplace.com/stock-quotes/aimd-stock-quote/">AIMD</a>) stock is taking an over 18% beating after announcing a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317930954&amp;type=PDF&amp;symbol=AIMD&amp;cdn=39410ef46d3e5a4f98cacc963fec77c6&amp;companyName=Ainos+Inc.&amp;formType=S-1%2FA&amp;formDescription=%5BAmend%5D+General+form+for+registration+of+securities+under+the+Securities+Act+of+1933&amp;dateFiled=2023-12-15">secondary share offering</a>.</li>



<li>Candel Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/cadl-stock-quote/">CADL</a>) shares are decreasing nearly 18% with the <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317928466&amp;type=PDF&amp;symbol=CADL&amp;cdn=6464cd4c70c3870400ff5f3e2b4b052b&amp;companyName=Candel+Therapeutics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-12-15">departure of its Chief Financial Officer</a>.</li>



<li>Near Intelligence (NASDAQ:<a href="https://investorplace.com/stock-quotes/nir-stock-quote/">NIR</a>) stock is dropping more than 17% this morning.</li>



<li>Safeguard Scientifics (NASDAQ:<a href="https://investorplace.com/stock-quotes/sfe-stock-quote/">SFE</a>) shares are falling over 17% on Monday.</li>



<li>Maison Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/mss-stock-quote/">MSS</a>) stock is sliding more than 16% <a href="https://seekingalpha.com/news/4046983-maison-solutions-plunges-following-hindenburg-tweet">alongside a short report</a>.</li>



<li>Farfetch (NYSE:<a href="https://investorplace.com/stock-quotes/ftch-stock-quote/">FTCH</a>) shares close out our pre-market stock movers down 16% this morning.</li>
</ol>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/12/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-dec-18th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Minerva Surgical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/utrs-stock-quote/">UTRS</a>) stock is taking a beating on Monday after the women&rsquo;s healthcare company announced that its shares will be delisted later this month.



According to <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317930347&amp;type=PDF&amp;symbol=UTRS&amp;cdn=c7474a358ea939d3c2d596e1cff4f9b4&amp;companyName=Minerva+Surgical+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-12-15">a filing with the Securities and Exchange Commission</a> (SEC), the company&rsquo;s shares will no longer trade on the Nasdaq Exchange starting on Dec. 29. This will follow a Form 25 filing with the SEC on Dec. 26. It will follow this up with a Form 15 filing on Jan. 4, 2024.



Investors will note that these filings won&rsquo;t require the company to publicly release earnings data. The company says that this will see it go dark when it comes to reporting performance. It also says that these changes will remove the burdens that come with filing with the SEC and remaining a public entity.



Minerva Surgical says the following about its delisting in <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=317930347&amp;type=PDF&amp;symbol=UTRS&amp;cdn=c7474a358ea939d3c2d596e1cff4f9b4&amp;companyName=Minerva+Surgical+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2023-12-15#page=4&amp;zoom=100,21,9">a press release</a>.




&ldquo;These time and expense savings can be used to execute the Company&rsquo;s operating plan, thus better enabling the Company to focus on its customers, its business and the patients whose lives are enhanced as a result of its work. With a more streamlined cost profile, the Company will be better able to invest in its business and focus on reducing its cash burn, and thus provide a future benefit to the Company&rsquo;s stockholders.&rdquo;




<h2>UTRS Stock Movement Today</h2>



With this delisting announcement comes some 26,000 shares of UTRS stock changing hands. That&rsquo;s still below its daily average trading volume of about 41,000 shares. It&rsquo;s also worth noting that UTRS is down 50% as of Monday morning.



Investors seeking out even more of the latest stock market stories are in the right place!



We have all of the hottest stock market news traders need to know about on Monday! That includes everything happening with shares of Ebix&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ebix-stock-quote/">EBIX</a>) stock, iCoreConnect&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/icct-stock-quote/">ICCT</a>) stock and Alaunos Therapeutics&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/tcrt-stock-quote/">TCRT</a>) stock today. All of that news is ready to go at the following links!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2023/12/why-is-ebix-ebix-stock-down-47-today/">Why Is Ebix (EBIX) Stock Down 47% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-icoreconnect-icct-stock-up-49-today/">Why Is iCoreConnect (ICCT) Stock Up 49% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-alaunos-therapeutics-tcrt-stock-up-37-today/">Why Is Alaunos Therapeutics (TCRT) Stock Up 37% Today?</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.



With only the rarest exceptions,&nbsp;InvestorPlace&nbsp;does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That&rsquo;s because these &ldquo;<a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>&rdquo; are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that&#8239;&nbsp;<a href="http://investorplace.com/" target="_blank">InvestorPlace.com</a>&rsquo;s&nbsp;writers disclose this fact and warn readers of the risks.&nbsp;



Read More:&#8239;Penny Stocks &mdash;&nbsp;<a href="https://investorplace.com/2014/05/fraud-penny-stocks-scams/" target="_blank">How to Profit Without Getting Scammed</a>
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/12/why-is-minerva-surgical-utrs-stock-down-50-today/">Why Is Minerva Surgical (UTRS) Stock Down 50% Today?</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Why Is Minerva Surgical (UTRS) Stock Down 50% Today?

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Adobe (NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) stock is in the news Monday as investors react to the company no longer moving forward with merger plans with Figma.



According to <a href="https://finance.yahoo.com/news/adobe-figma-mutually-agree-terminate-130000169.html">a press release from Adobe</a>, the two companies came to a mutual agreement to end the $20 billion merger deal. Investors will remember that this would have seen Adobe acquire Figma with a mix of cash and stock.



Adobe also says that the reason for the termination of the merger is decisions made by regulators in Europe and the U.K. These don&rsquo;t leave it with a path to move forward with the deal, which is why the two companies are calling it off.



Shantanu Narayen, chair and CEO of Adobe, said the following about the news.




&ldquo;While Adobe and Figma shared a vision to jointly redefine the future of creativity and productivity, we continue to be well positioned to capitalize on our massive market opportunity and mission to change the world through personalized digital experiences.&rdquo;




<h2>How This Affects ADBE Stock</h2>



Despite news of the merger termination, shares of ADBE stock are up 1.5% as of Monday morning. That comes alongside some 221,000 shares changing hands. That&rsquo;s still a far way off from its daily average trading volume of about 2.9 million shares.



It makes sense that ADBE shares are getting a boost from today&rsquo;s news. In these types of mergers, the company making the acquisition often sees its stock dip on the news. That has today&rsquo;s jump helping ADBE regain lost ground. It could also be that investors weren&rsquo;t a fan of the merger plan.



Investors seeking out even more of the most recent stock market stories for today are in the right place!



InvestorPlace is home to all of the hottest stock market stories that traders need to know about on Monday! Among that is what&rsquo;s happening with shares of Minerva Surgical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/utrs-stock-quote/">UTRS</a>), Ebix&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/ebix-stock-quote/">EBIX</a>) and iCoreConnect&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/icct-stock-quote/">ICCT</a>) stock today. You can catch up on all of these matters at the following links!



<h2>More Monday Stock Market News</h2>



<ul><li><a href="https://investorplace.com/2023/12/why-is-minerva-surgical-utrs-stock-down-50-today/">Why Is Minerva Surgical (UTRS) Stock Down 50% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-ebix-ebix-stock-down-47-today/">Why Is Ebix (EBIX) Stock Down 47% Today?</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-icoreconnect-icct-stock-up-49-today/">Why Is iCoreConnect (ICCT) Stock Up 49% Today?</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/12/adbe-stock-alert-adobe-and-figma-terminate-merger-agreement/">ADBE Stock Alert: Adobe and Figma Terminate Merger Agreement</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

ADBE Stock Alert: Adobe and Figma Terminate Merger Agreement

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Nokia (NYSE:<a href="https://investorplace.com/stock-quotes/nok-stock-quote/">NOK</a>) stock is on the move Monday after Goldman Sachs changed its stance on the tech company&rsquo;s shares with a new rating.



Goldman Sachs analyst Alexander Duval <a href="https://seekingalpha.com/news/4047330-nokia-goldman-sachs-downgrades-product-competition-concerns">downgraded shares of NOK stock</a> from a &ldquo;buy&rdquo; rating to a &ldquo;neutral&rdquo; rating today. To add some perspective, the analysts&rsquo; consensus rating for NOK shares is hold based on seven opinions.



In addition to that downgrade, the Goldman Sachs analyst also lowered the firm&rsquo;s price target for NOK stock from $5.10 to $3.40. That still represents a potential upside of 4.3% for the shares. However, it&rsquo;s below the <a href="https://www.marketbeat.com/stocks/NYSE/NOK/price-target/">analysts&rsquo; consensus price prediction</a> of $5.06 per share.



<h2>What&rsquo;s Behind the NOK Stock Downgrade?</h2>



Here&rsquo;s what Duval said about Nokia stock in a note to clients obtained by Seeking Alpha.




&ldquo;While we believe we were correct historically to identify that Nokia had made some progress in improving its wireless portfolio, we are now less confident on their ability to win back as much share based on product improvement given the AT&amp;T loss.&rdquo;




With today&rsquo;s news comes a nearly 1% drop for NOK stock as of Monday morning. That movement comes alongside 1.7 million shares changing hands with the company&rsquo;s daily average being 18 million shares.



Investors searching for even more of the hottest stock market stories to read about today are in the right place!



We have all of the most recent stock market coverage that traders need to know about on Monday! A few examples include why shares of Nio&nbsp;(NYSE:<a href="https://investorplace.com/stock-quotes/nio-stock-quote/">NIO</a>), Adobe&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/adbe-stock-quote/">ADBE</a>) and Minerva Surgical&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/utrs-stock-quote/">UTRS</a>) stock are on the move today. You can catch up on all of these matters by checking out the links below!



<h2>More Stock Market News for Monday</h2>



<ul><li><a href="https://investorplace.com/2023/12/nio-stock-alert-nio-surges-on-a-2-2-billion-investment/">NIO Stock Alert: Nio Surges on a $2.2 Billion Investment</a></li>



<li><a href="https://investorplace.com/2023/12/adbe-stock-alert-adobe-and-figma-terminate-merger-agreement/">ADBE Stock Alert: Adobe and Figma Terminate Merger Agreement</a></li>



<li><a href="https://investorplace.com/2023/12/why-is-minerva-surgical-utrs-stock-down-50-today/">Why Is Minerva Surgical (UTRS) Stock Down 50% Today?</a></li>
</ul>On the date of publication, William White&nbsp;did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/05/secret-income-blueprint-of-the-one-percent/?cid=MKT730394&amp;eid=MKT771243">The Rich Use This Income Secret (NOT Dividends) Far More Than Regular Investors</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2023/12/goldman-sachs-is-souring-on-nokia-nok-stock/">Goldman Sachs Is Souring on Nokia (NOK) Stock</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Goldman Sachs Is Souring on Nokia (NOK) Stock

These Healthcare stocks are trading higher:-Panbela Therapeutics Inc (PBLA) stock is trading at $1.43, an increase of $0.97, or 207.37%, on high volume.  Panbela Therapeutics Inc gets a Sentiment Score of Very Bearish from InvestorsObserver and receives an average analyst recommendation of Strong Buy with a price target of

Healthcare Stocks Making Moves Monday: PBLA, IVVD, BMRA, ZIMV, UTRS, CKPT, LNTH, FBIO

A rating of 76 puts Minerva Surgical Inc (UTRS) near the top of the Health Information Services industry according to InvestorsObserver. Minerva Surgical Inc's score of 76 means it scores higher than 76% of stocks in the industry. Minerva Surgical Inc also received an overall rating of 45, putting it above 45% of all stock

Comments

Minerva Surgical

Notizie

Ultime notizie per Minerva Surgical (OTC:UTRS) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO